Talal Exploring Telemedicine’s Role in Treating Hepatitis C

Updated August 5, 2016 This content is archived.

A research team led by Andrew Talal, MD, professor of medicine, has received $7 million from the Patient-Centered Outcomes Research Institute to compare the effectiveness of telemedicine provided in methadone clinics versus referral to a liver specialist to treat hepatitis C in drug users.